Skip to content

The connection between atypical antipsychotic drugs and endocrine

The influence of atypical antipsychotic drugs on the endocrine function of patients with severe mental disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113238
Enrollment
Unknown
Registered
2025-11-26
Start date
2024-08-07
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Explore the effects of different atypical antipsychotic drugs on the endocrine function of patients with first-episode severe mental disorders (schizophrenia, depression, bipolar disorder).

Interventions

Schizophrenia group:None
Depression group:None

Sponsors

Shandong mental health center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria of schizophrenia, depression and bipolar disorder in the International Statistical Classification of Diseases and Related Health Problems (10th Revision) (ICD-10); 2.Patients with schizophrenia, depression and bipolar disorder mainly treated with atypical antipsychotic drugs; 3. age >=18 and <=65 years; 4.Having no history of thyroid diseases, kidney diseases and endocrine-related diseases in the past, and various examinations after admission excluded endocrine-related diseases before medication; 5. Having no history of abuse or dependence on psychoactive substances;

Exclusion criteria

Exclusion criteria: 1.Patients with severe and unstable somatic diseases, family history of mental diseases and "three highs"; 2.Patients with pituitary tumors, hypothalamic lesions, thyroid diseases, kidney diseases and other endocrine diseases; 3.Patients who were previously treated with second-generation antipsychotic drugs but were ineffective; 4. Women who are pregnant or lactating; 5.Patients taking drugs that affect thyroid and adrenal functions, such as lithium carbonate, are excluded.

Design outcomes

Primary

MeasureTime frame
Thyroid hormones (T3, T4);thyroid stimulating hormone (TSH);blood glucose;insulin;C-peptide;cortisol;epinephrine;norepinephrine;testosterone;estradiol;progesterone;growth hormone;growth hormone releasing;uric acid;homocysteine;Cholesterol;

Countries

China

Contacts

Public ContactRanRan Li

Shandong mental health center

dtlrr113@126.com+86 186 7877 7190

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026